{
    "2018-07-23": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Top Analyst Reports for Johnson & Johnson, Nike & Schlumberger",
                "features": {
                    "keywords": [
                        "analyst reports",
                        "Johnson & Johnson",
                        "Nike",
                        "Schlumberger"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "How The Parts Add Up: IWL Targets $72",
                "features": {
                    "keywords": [
                        "IWL",
                        "targets",
                        "$72"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "index funds"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Is Danaher (DHR) Outperforming Other Conglomerates Stocks This Year?",
                "features": {
                    "keywords": [
                        "Danaher",
                        "outperforming",
                        "conglomerates",
                        "stocks"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "industrial conglomerates"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "FSD Pharma Appoints a Special Committee of the Board for Mergers and Acquisitions and Interim Chief Financial Officer",
                "features": {
                    "keywords": [
                        "FSD Pharma",
                        "special committee",
                        "mergers and acquisitions",
                        "interim CFO"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}